Related Experiment Video
Updated: May 24, 2025

09:33
Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
7.9K
Gut microbiota may affect Alzheimer's disease through synaptic function mediated by CAMs pathway: A study combining
Ji-Yun Liu1, Cong-Yan Tan2, Li Luo1
1Department of Clinical Laboratory, Guiyang Second People's Hospital, Guiyang, China.
Journal of Alzheimer'S Disease Reports
|March 4, 2025
Summary
Gut microbes are linked to Alzheimer's disease (AD) progression. Specific bacteria like Bifidobacterium adolescentis may influence AD through cell adhesion molecule signaling, suggesting gut microbiome analysis for early AD detection.
Area of Science:
- Microbiology
- Neuroscience
- Genetics
Background:
- The relationship between gut microbiota and Alzheimer's disease (AD) pathogenesis remains incompletely understood.
- Investigating specific microbial contributions to AD is crucial for understanding disease mechanisms.
Purpose of the Study:
- To establish a causal link between gut microbes and Alzheimer's disease (AD).
- To explore the pathogenic roles of specific microbes in AD development.
Main Methods:
- Mendelian randomization analyses were employed to identify causal relationships between gut microbes and AD.
- Protein-protein interaction (PPI) networks identified key hub genes.
- Functional enrichment analysis elucidated theoretical pathogenesis pathways.
Main Results:
- Thirty-two microbes showed significant associations with AD.
- DLGAP2, NRXN3, NEGR1, NTNAP2, MYH9, and SCN3A were identified as hub genes.
- NRXN3, NEGR1, and NTNAP2 genes are involved in cell adhesion molecule (CAM) signaling, linked to Bifidobacterium adolescentis, Actinomycetales, and Intestinimonas massiliensis.
Conclusions:
- Bifidobacterium adolescentis, Actinomycetales, and Intestinimonas massiliensis may drive AD progression via CAM signaling pathways affecting synaptic function.
- Further research into the gut microbiome could enhance AD screening and diagnosis.

